OpGen, Inc. (NASDAQ:OPGN – Get Free Report)’s share price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $1.99 and traded as low as $0.00. OpGen shares last traded at $0.00, with a volume of 1 shares trading hands.
OpGen Stock Down 100.0%
The business has a 50 day moving average of $1.99 and a 200 day moving average of $3.01.
OpGen Company Profile
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Featured Stories
- Five stocks we like better than OpGen
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- PayPal Stock: Why Wall Street May Be Undervaluing This Giant
- Investing In Preferred Stock vs. Common Stock
- Why Vertical Aerospace Could Lead the eVTOL Market by 2028
- How to Use the MarketBeat Dividend Calculator
- Is Draganfly’s Army Partnership a Game-Changer for Investors?
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
